India IPO Pipeline SEBI Regulatory Filings — March 15, 2026

Board meeting April 22-23 for Q4/FY26 results approval, high materiality 9/10 signals market-moving event

Potential final dividend recommendation post-results, consistent with capital allocation trends in IT peers

Investor/analyst calls on April 23 to discuss results and business outlook, opportunity for positive guidance

Trading window closure March 16-April 27 per SEBI PIT regs ensures compliance, no unusual insider selling reported

Audited INDAS/IFRS results presentation, enabling accurate period-over-period YoY/QoQ trend analysis

No insider trading activity or pledges noted pre-window close, indicating stable management conviction

FY26 year-end results (March 31) align with sector earnings calendar, potential for margin/ROE outperformance

Neutral sentiment with forward-looking calls, historical dividend track record supports yield enhancement

Capital allocation focus via dividend if recommended, vs reinvestment, gauges financial health post-Q4

Scheduled events cluster (board + calls) compresses catalyst timeline, amplifying short-term alpha

SEBI compliance reinforces governance strength, relative to IPO pipeline firms with regulatory scrutiny

No guidance changes flagged yet, but outlook discussion could raise FY27 targets

Trading window closed March 16-27, 2026, restricting buys/sells, potential for pent-up activity post-reopen

Q4/FY26 results pending, neutral sentiment may mask YoY revenue/margin misses if IT spending slows

Final dividend 'if any' - conditional language flags possible skip amid capex pressures

Business outlook call April 23 could reveal conservative FY27 guidance vs expectations

Strict SEBI PIT adherence, any violation history (none noted) could trigger probes

Absent enriched YoY/QoQ data, risk of margin compression or debt/equity deterioration in results

Dividend deferral possible if cash preserved for M&A, diverging from payout history

Concentrated catalysts (Apr 22-23) heighten volatility risk around results miss

Position pre-April 22 board meeting for potential dividend yield surprise and outlook beat

Final dividend recommendation could boost yield vs IT sector avg, trade record date post-approval

April 23 investor calls for business guidance - alpha from raised FY27 targets or IT demand reaffirm

Buy opportunity April 27 post-results if positive, as window closure limited insider noise

SEBI compliance and audited results under INDAS/IFRS support relative valuation lift

High materiality 9/10 event positions Infosys as bellwether for FY26 trends in IPO pipeline context

Monitor dividend vs buyback hints, opportunity if payout exceeds YoY prior years

Earnings straddle trade around Apr 22-23, leveraging neutral sentiment for options play

Single filing signals early FY26 board approvals (Apr 22-23), theme of accelerated disclosures vs typical May/June, implies strong pipeline visibility [IMPLICATION: Front-run sector rotation]

Potential 'if any' final dividend highlights cautious capital allocation in IT amid growth capex, aggregate neutral sentiment [IMPLICATION: Yield hunters monitor payouts]

Trading window closures (Mar 16-Apr 27) enforce SEBI PIT across filings, no activity patterns yet [IMPLICATION: Post-reopen for conviction buys]

Board + investor calls on Apr 22-23 compress events, pattern for high-impact weeks in services sector [IMPLICATION: Heightened volatility, tactical trades]

1/1 filings neutral, with high materiality, suggests balanced FY26 outlooks pre-results [IMPLICATION: Upside skew if beats materialize]

SEBI PIT emphasis in filings underscores governance in listed vs IPO pipeline firms [IMPLICATION: Premium for compliant leaders like Infosys]

Approve Q4/FY26 results and dividend - watch for YoY revenue growth, margin trends April 22-23, 2026

Business outlook discussion, flag guidance changes or FY27 forecasts April 23, 2026

Reopen April 27, 2026 - monitor insider buys/sells/pledges for conviction post-results

Post-approval announcement, track for yield impact and shareholder returns

Post-results check Debt-to-Equity, ROE, margins vs prior QoQ/YoY for trend breaks

Dividend vs buyback/splits hints in meeting, assess reinvestment signals

Volumes, capacity, costs in results - outlier vs IT peers for relative performance

Any SEBI PIT deviations or additional compliance notes around window closure